COMMUNIQUÉS West-GlobeNewswire

Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
21/02/2018
New Infusion Set Offers Simpler, Faster, and More Convenient 1 Insulin Pump Experience DUBLIN - February 21, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, services and solutions, today [...]
Imprivata to Showcase Customer Success with E-prescribing for Opioids at HIMSS18
21/02/2018
LEXINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, will showcase innovative technologies, customer success stories, and best practices for enabling electronic [...]
La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study
21/02/2018
SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that the first pediatric patient has been treated in LJ501-CRH02, La Jolla’s open-label study of GIAPREZA TM ( [...]
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
21/02/2018
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News covered the Company’s recent [...]
Tyme Technologies Appoints Tommy G. Thompson to Board of Directors
21/02/2018
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of former Wisconsin governor [...]
Abeona Therapeutics Announces Upcoming Conference Participation
21/02/2018
NEW YORK and CLEVELAND, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
21/02/2018
FIT Biotech Oy Company release February 21, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]
CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences
21/02/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]
Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee
21/02/2018
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results
21/02/2018
SOLANA BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will [...]
Tower One Announces Final Approval and Implementation of Warrant Incentive Program and Warrant Listing on Canadian Securities Exchange
21/02/2018
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company ”) announces, further to its news release dated January 9, [...]
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences
21/02/2018
TUSTIN, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]
Allscripts to present at 2018 RBC Capital Markets Global Healthcare Conference
21/02/2018
CHICAGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) today announced that certain members of its management team will present at the 2018 RBC Capital Markets Global Healthcare Conference, to be held at [...]
Premier Biomedical Inc., CEO William Hartman Returns to Uptick Newswire’s “Stock Day” with Everett Jolly
21/02/2018
PHOENIX, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC:BIEI) President & CEO, William A. Hartman today reviewed operational accomplishments of 2017 and expectations for 2018 in an interview on [...]
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
21/02/2018
--Ended 2017 with a healthy cash position of $380M -- --Recently announced FDA approval and launch of Glatopa ® 40 mg-- CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ) [...]
Dr. Eugene Sun Appointed to Novan Board of Directors
21/02/2018
Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEO Will provide expert perspective on the clinical application of the underlying nitric oxide science Will chair [...]
Amicus Therapeutics to Announce Full-Year 2017 Financial Results on February 28, 2018
21/02/2018
CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced a conference call and live audio webcast on Wednesday, February 28, 2018 at 8:30 a.m. ET to discuss financial results [...]
TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib in The Lancet Oncology
21/02/2018
Umbralisib is structurally distinct from other PI3K delta inhibitors with greater selectivity to PI3K delta and unique complementary inhibition of casein kinase-1 (CK1) epsilon Single agent umbralisib was well tolerated [...]
Recro Pharma to Host Analyst and Investor Day on February 28, 2018
21/02/2018
MALVERN, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Pages